[Human hybridoma neutralizing antibodies to the herpes simplex virus]. 1992

A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ

Human hybridoma cells producing monoclonal antibodies to human herpes simplex virus were generated. The antibody produced by the hybrid cells interacted with herpes virus types I and II in enzyme immunoassay and complement fixation test, had neutralizing activity both in vivo and in vitro. These human monoclonal antibodies may be used for immunotherapy of herpes virus infection.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002459 Cell Fusion Fusion of somatic cells in vitro or in vivo, which results in somatic cell hybridization. Cell Fusions,Fusion, Cell,Fusions, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D004854 Herpesvirus 4, Human The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies. Burkitt Herpesvirus,Burkitt Lymphoma Virus,E-B Virus,EBV,Epstein-Barr Virus,Human Herpesvirus 4,Infectious Mononucleosis Virus,Burkitt's Lymphoma Virus,HHV-4,Herpesvirus 4 (gamma), Human,Burkitts Lymphoma Virus,E B Virus,E-B Viruses,Epstein Barr Virus,Herpesvirus, Burkitt,Infectious Mononucleosis Viruses,Lymphoma Virus, Burkitt,Mononucleosis Virus, Infectious,Mononucleosis Viruses, Infectious
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
January 1971, Archivos de investigacion medica,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
January 1985, The Indian journal of medical research,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
June 1952, Journal of immunology (Baltimore, Md. : 1950),
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
December 1976, Medical microbiology and immunology,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
June 1981, Journal of periodontology,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
March 1983, The Journal of infectious diseases,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
November 1987, Journal of virology,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
June 1974, The Journal of infectious diseases,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
January 1989, Journal of medical virology,
A A Kushch, and Sh M Tugizov, and E N Terletskaia, and T A Posevaia, and A A Nikitina, and N D L'vov, and I F Barinskiĭ
January 1979, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!